BACKGROUND. The frequency of the hemolytic uremic syndrome, characterized by microangiopathic hemolytic anemia, thrombocytopenia, and renal failure, is increasing. Although Escherichia coli serotype 0157:H7 has been implicated as a causative agent, more information is needed about the basic epidemiology and clinical aspects of this syndrome. METHODS. We conducted a retrospective population-based study of hemolytic uremic syndrome in Minnesota residents less than 18 years of age from 1979 through 1988 to assess trends in disease occurrence, describe the clinical illness, and identify predictors of disease severity and outcome. We also conducted a case-control study of patients with onsets of illness from 1986 through 1988 to examine risk factors. RESULTS. One hundred seventeen patients were identified. The mean annual incidence increased from 0.5 case per 100,000 child-years among children less than 18 in 1979 (6 cases) to 2.0 cases per 100,000 in 1988 (26 cases) (P = 0.000004). E. coli 0157:H7 was isolated from 13 of 28 patients (46 percent) who had stool specimens submitted for testing. For those who presented with typical hemolytic uremic syndrome, an elevated polymorphonuclear-leukocyte count on hospital admission, a shorter duration of prodrome, and the presence of bloody diarrhea were predictive of severe disease. In the case-control study, the patients were more likely to attend large daycare centers (more than 50 children) than were the controls (odds ratio, 10.2; P = 0.03), suggesting that day-care attendance may be a risk factor. On the basis of the population-attributable risk, however, this factor could account for no more than 16 percent of the cases. CONCLUSIONS. This study provides evidence for an increase in the incidence of hemolytic uremic syndrome, which is probably related to an increased incidence of E. coli 0157:H7 infections. Hemolytic uremic syndrome has become an important pediatric and public health problem.
Source Information
Acute Disease Epidemiology Section, Minnesota Department of Health, Minneapolis 55440.
This article has been cited by other articles:
Suri, R. S., Clark, W. F., Barrowman, N., Mahon, J. L., Thiessen-Philbrook, H. R., Rosas-Arellano, M. P., Zarnke, K., Garland, J. S., Garg, A. X.
(2005). Diabetes During Diarrhea-Associated Hemolytic Uremic Syndrome: A systematic review and meta-analysis. Diabetes Care
28: 2556-2562
[Abstract][Full Text]
Ake, J. A., Jelacic, S., Ciol, M. A., Watkins, S. L., Murray, K. F., Christie, D. L., Klein, E. J., Tarr, P. I.
(2005). Relative Nephroprotection During Escherichia coli O157:H7 Infections: Association With Intravenous Volume Expansion. Pediatrics
115: e673-e680
[Abstract][Full Text]
Gavin, P. J., Peterson, L. R., Pasquariello, A. C., Blackburn, J., Hamming, M. G., Kuo, K. J., Thomson, R. B. Jr.
(2004). Evaluation of Performance and Potential Clinical Impact of ProSpecT Shiga Toxin Escherichia coli Microplate Assay for Detection of Shiga Toxin-Producing E. coli in Stool Samples. J. Clin. Microbiol.
42: 1652-1656
[Abstract][Full Text]
Bruce, M. G., Curtis, M. B., Payne, M. M., Gautom, R. K., Thompson, E. C., Bennett, A. L., Kobayashi, J. M.
(2003). Lake-Associated Outbreak of Escherichia coli O157:H7 in Clark County, Washington, August 1999. Arch Pediatr Adolesc Med
157: 1016-1021
[Abstract][Full Text]
Garg, A. X., Suri, R. S., Barrowman, N., Rehman, F., Matsell, D., Rosas-Arellano, M. P., Salvadori, M., Haynes, R. B., Clark, W. F.
(2003). Long-term Renal Prognosis of Diarrhea-Associated Hemolytic Uremic Syndrome: A Systematic Review, Meta-analysis, and Meta-regression. JAMA
290: 1360-1370
[Abstract][Full Text]
Safdar, N., Said, A., Gangnon, R. E., Maki, D. G.
(2002). Risk of Hemolytic Uremic Syndrome After Antibiotic Treatment of Escherichia coli O157:H7 Enteritis: A Meta-analysis. JAMA
288: 996-1001
[Abstract][Full Text]
Molbak, K., Mead, P. S., Griffin, P. M.
(2002). Antimicrobial Therapy in Patients With Escherichia coli O157:H7 Infection. JAMA
288: 1014-1016
[Full Text]
Kehl, S. C.
(2002). Role of the Laboratory in the Diagnosis of Enterohemorrhagic Escherichia coli Infections. J. Clin. Microbiol.
40: 2711-2715
[Full Text]
TAGUCHI, H., TAKAHASHI, M., YAMAGUCHI, H., OSAKI, T., KOMATSU, A., FUJIOKA, Y., KAMIYA, S.
(2002). Experimental infection of germ-free mice with hyper-toxigenic enterohaemorrhagic Escherichia coli O157:H7, strain 6. J Med Microbiol
51: 336-343
[Abstract][Full Text]
George, J. N., Sadler, J. E., Lammle, B.
(2002). Platelets: Thrombotic Thrombocytopenic Purpura. ASH Education Book
2002: 315-334
[Abstract][Full Text]
Elliott, E J, Robins-Browne, R M, O'Loughlin, E V, Bennett-Wood, V, Bourke, J, Henning, P, Hogg, G G, Knight, J, Powell, H, Redmond, D, Contributors to the Australian Paediatric Surveill,
(2001). Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features. Arch. Dis. Child.
85: 125-131
[Abstract][Full Text]
Novicki, T. J., Daly, J. A., Mottice, S. L., Carroll, K. C.
(2000). Comparison of Sorbitol MacConkey Agar and a Two-Step Method Which Utilizes Enzyme-Linked Immunosorbent Assay Toxin Testing and a Chromogenic Agar To Detect and Isolate Enterohemorrhagic Escherichia coli. J. Clin. Microbiol.
38: 547-551
[Abstract][Full Text]
White, D. J., Talarico, J., Chang, H.-G., Birkhead, G. S., Heimberger, T., Morse, D. L.
(1998). Human Babesiosis in New York State: Review of 139 Hospitalized Cases and Analysis of Prognostic Factors. Arch Intern Med
158: 2149-2154
[Abstract][Full Text]
Paton, J. C., Paton, A. W.
(1998). Pathogenesis and Diagnosis of Shiga Toxin-Producing Escherichia coli Infections. Clin. Microbiol. Rev.
11: 450-479
[Abstract][Full Text]
Cabrera, G. R., Fortenberry, J. D., Warshaw, B. L., Chambliss, C. R., Butler, J. C., Cooperstone, B. G.
(1998). Hemolytic Uremic Syndrome Associated With Invasive Streptococcus pneumoniae Infection. Pediatrics
101: 699-699
[Full Text]
Nataro, J. P., Kaper, J. B.
(1998). Diarrheagenic Escherichia coli. Clin. Microbiol. Rev.
11: 142-201
[Abstract][Full Text]
Bell, B. P., Griffin, P. M., Lozano, P., Christie, D. L., Kobayashi, J. M., Tarr, P. I.
(1997). Predictors of Hemolytic Uremic Syndrome in Children During a Large Outbreak of Escherichia coli O157:H7 Infections. Pediatrics
100: e12-e12
[Abstract][Full Text]
Seifter, J. L., Nickeleit, V.
(1997). Case 17-1997- A 67-Year-Old Woman with Vomiting, Bloody Diarrhea, and Azotemia. NEJM
336: 1587-1594
[Full Text]
Tarr, P. I., Fouser, L. S., Stapleton, A. E., Wilson, R. A., Kim, H. H., Vary, J. C., Clausen, C. R.
(1996). Hemolytic-Uremic Syndrome in a Six-Year-Old Girl after a Urinary Tract Infection with Shiga-Toxin-Producing Escherichia coli O103:H2. NEJM
335: 635-638
[Full Text]
Boyce, T. G., Swerdlow, D. L., Griffin, P. M.
(1995). Escherichia coli O157:H7 and the Hemolytic-Uremic Syndrome. NEJM
333: 364-368
[Full Text]
Figueras, J., Roldan, A., Botet, F., Palacin, A., Jimenez, R.
(1995). Neonatal Hemolytic-Uremic Syndrome. CLIN PEDIATR
34: 220-222